tradingkey.logo
tradingkey.logo
検索

Apyx Medical Corp

APYX
ウォッチリストに追加
3.870USD
-0.180-4.44%
終値 05/18, 16:00ET15分遅れの株価
162.05M時価総額
損失額直近12ヶ月PER

Apyx Medical Corp

3.870
-0.180-4.44%

詳細情報 Apyx Medical Corp 企業名

Apyx Medical Corporation is an advanced energy technology company. The Company's segments include Advanced Energy and Original Equipment Manufacturer (OEM). The Advanced Energy segment's product portfolio consists of Helium Plasma Technology, which is marketed and sold as Renuvion in the cosmetic surgery market, and J-Plasma in the hospital surgical market. It focuses on the cosmetic surgery market, where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. These product lines consist of a multifunction generator, a handpiece and a supply of helium gas. Through OEM agreements, the OEM segment produces generators, medical devices, and related accessories for medical device manufacturers as well as start-up businesses in need of its energy-based designs. It specializes in the design, development, and manufacturing of electrosurgical equipment and medical devices.

Apyx Medical Corpの企業情報

企業コードAPYX
会社名Apyx Medical Corp
上場日Jul 22, 1983
最高経営責任者「CEO」Goodwin (Charles D)
従業員数220
証券種類Ordinary Share
決算期末Jul 22
本社所在地5115 Ulmerton Rd
都市CLEARWATER
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号33760-4004
電話番号18005372790
ウェブサイトhttps://apyxmedical.com/
企業コードAPYX
上場日Jul 22, 1983
最高経営責任者「CEO」Goodwin (Charles D)

Apyx Medical Corpの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
1.75M
--
Mr. Moshe Citronowicz
Mr. Moshe Citronowicz
Senior Vice President
Senior Vice President
493.50K
+7.50%
Mr. Lawrence J. (Larry) Waldman, CPA
Mr. Lawrence J. (Larry) Waldman, CPA
Lead Independent Director
Lead Independent Director
42.90K
--
Mr. Shawn David Roman
Mr. Shawn David Roman
Chief Operating Officer
Chief Operating Officer
12.00K
--
Mr. Matthew C. (Matt) Hill
Mr. Matthew C. (Matt) Hill
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
8.50K
--
Mr. Charles D. Goodwin, II
Mr. Charles D. Goodwin, II
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
--
--
Ms. Wendy Levine
Ms. Wendy Levine
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
1.75M
--
Mr. Moshe Citronowicz
Mr. Moshe Citronowicz
Senior Vice President
Senior Vice President
493.50K
+7.50%
Mr. Lawrence J. (Larry) Waldman, CPA
Mr. Lawrence J. (Larry) Waldman, CPA
Lead Independent Director
Lead Independent Director
42.90K
--
Mr. Shawn David Roman
Mr. Shawn David Roman
Chief Operating Officer
Chief Operating Officer
12.00K
--
Mr. Matthew C. (Matt) Hill
Mr. Matthew C. (Matt) Hill
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
8.50K
--
Mr. Charles D. Goodwin, II
Mr. Charles D. Goodwin, II
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--

収益内訳

通貨: USD更新時刻: Mon, Apr 6
通貨: USD更新時刻: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
会社から関連データがまだ開示されていません。
地域別USD
会社名
収益
比率
Domestic
38.80M
73.43%
International
14.04M
26.57%
事業別
地域別
会社から関連データがまだ開示されていません。

株主

更新時刻: Thu, May 14
更新時刻: Thu, May 14
株主統計
種類
株主統計
株主統計
比率
Nantahala Capital Management, LLC
9.82%
Archon Capital Management LLC
7.67%
Vanderfelt (William Weeks)
7.54%
Royce Investment Partners
6.24%
Vizirgianakis (Stavros G)
4.17%
他の
64.56%
株主統計
株主統計
比率
Nantahala Capital Management, LLC
9.82%
Archon Capital Management LLC
7.67%
Vanderfelt (William Weeks)
7.54%
Royce Investment Partners
6.24%
Vizirgianakis (Stavros G)
4.17%
他の
64.56%
種類
株主統計
比率
Hedge Fund
19.50%
Individual Investor
13.26%
Investment Advisor
12.93%
Investment Advisor/Hedge Fund
11.52%
Private Equity
1.92%
Research Firm
0.80%
Bank and Trust
0.46%
Family Office
0.18%
Pension Fund
0.08%
他の
39.34%

機関投資家保有株

更新時刻: Wed, Apr 1
更新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株式数
比率
変動額
2026Q1
105
19.57M
46.73%
+1.35M
2025Q4
93
15.65M
47.11%
--
2025Q3
106
16.17M
54.10%
-179.30K
2025Q2
111
16.35M
54.58%
+38.20K
2025Q1
115
16.92M
61.27%
-6.24M
2024Q4
121
17.05M
55.05%
+3.13M
2024Q3
126
13.93M
65.05%
-228.66K
2024Q2
141
15.10M
68.01%
-305.66K
2024Q1
168
15.41M
70.58%
-9.04M
2023Q4
180
18.49M
72.63%
-941.37K
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Nantahala Capital Management, LLC
4.11M
9.83%
+138.61K
+3.49%
Mar 09, 2026
Archon Capital Management LLC
3.21M
7.68%
--
--
Mar 09, 2026
Vanderfelt (William Weeks)
3.16M
7.55%
--
--
Mar 09, 2026
Royce Investment Partners
2.44M
5.84%
--
--
Mar 09, 2026
Vizirgianakis (Stavros G)
1.75M
4.17%
--
--
Mar 09, 2026
Silverberg Bernstein Capital Management, LLC
1.03M
2.47%
+46.50K
+4.71%
Dec 31, 2025
AIGH Capital Management, LLC.
805.52K
1.93%
+805.52K
--
Dec 31, 2025
Commonwealth Financial Network
663.54K
1.59%
--
--
Dec 31, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
iShares Micro-Cap ETF
0.02%
Avantis US Equity ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
比率0.02%
Avantis US Equity ETF
比率0%
Avantis US Small Cap Equity ETF
比率0%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
KeyAI